Tag: Cancer: Rectal
Survival Up With Nivolumab + Ipilimumab Versus Chemo for Metastatic CRC
Findings seen in patients with microsatellite-instability-high or mismatch-repair-deficient metastatic colorectal cancer
Centralized CRC Screening Outreach Intervention Improves Screening Rates
Intervention participants were more likely to complete screening and to have detection of advanced colorectal neoplasia
Colorectal Cancer Risk Factors Important to Consider for Rescreening Interval
Findings seen for individuals with previous negative colonoscopy screening
Racial, Ethnic Disparities Seen in Mortality With Early-Onset Colorectal Cancer
Some of the differences explained by social determinants of health
Risk Factors Found for Neurogenic Bladder After Rectal Cancer Surgery
Lower abdominal visceral fat area and prolonged surgery are independent risk factors
ACG: GLP-1 RAs Tied to Lower Risk for Early-Onset Colorectal Cancer
Findings seen in people with type 2 diabetes
ACG: 2000 to 2022 Saw Rise in Early-Onset CRC Mortality in the United States
Increase in mortality seen in both early- and late-stage tumors
Cell-Free Blood DNA Tests Less Effective Than Other CRC Screening
cf-bDNA costs $89,600 per quality-adjusted life year gained, with alternatives less costly and more effective
Restaging MRI Can Predict Survival With Rectal Cancer
Findings can save some lower-risk patients surgery after chemo, radiation
FIT Completion, Yield Rates Similar in Those Aged 45 to 49 Versus 50 Years
For individuals aged 45 to 49 years, FIT completion slightly higher while FIT positivity slightly lower
